SALIX PHARMACEUTICALS LTD
10-Q, EX-27.1, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: SALIX PHARMACEUTICALS LTD, 10-Q, EX-10.27, 2000-08-14
Next: NETOBJECTS INC, 10-Q, 2000-08-14



<TABLE> <S> <C>

<ARTICLE> 5



<S>                          <C>
<PERIOD-TYPE>                6-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-START>                                 JAN-01-2000
<PERIOD-END>                                   JUN-30-2000
<CASH>                                             7,489
<SECURITIES>                                           0
<RECEIVABLES>                                        193
<ALLOWANCES>                                           0
<INVENTORY>                                        1,170
<CURRENT-ASSETS>                                   9,230
<PP&E>                                               559
<DEPRECIATION>                                       419
<TOTAL-ASSETS>                                     9,522
<CURRENT-LIABILITIES>                                  0
<BONDS>                                                0
                                  0
                                            0
<COMMON>                                          27,922
<OTHER-SE>                                       (23,343)
<TOTAL-LIABILITY-AND-EQUITY>                       9,522
<SALES>                                              553
<TOTAL-REVENUES>                                   9,925
<CGS>                                                535
<TOTAL-COSTS>                                        535
<OTHER-EXPENSES>                                   7,350
<LOSS-PROVISION>                                       0
<INTEREST-EXPENSE>                                     0
<INCOME-PRETAX>                                    2,069
<INCOME-TAX>                                           0
<INCOME-CONTINUING>                                    0
<DISCONTINUED>                                         0
<EXTRAORDINARY>                                        0
<CHANGES>                                              0
<NET-INCOME>                                       2,069
<EPS-BASIC>                                         0.19
<EPS-DILUTED>                                       0.19


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission